Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate

BACKGROUND: Studies suggest that patients with relapsing–remitting multiple sclerosis (RRMS) who fail to benefit from a disease-modifying treatment (DMT) may benefit from converting to another DMT class. COPTIMIZE was a 24-month observational study designed to assess the disease course of patients c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemssen, Tjalf, Gilgun-Sherki, Yossi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599648/
https://www.ncbi.nlm.nih.gov/pubmed/26450155
http://dx.doi.org/10.1186/s12883-015-0448-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599648/
https://www.ncbi.nlm.nih.gov/pubmed/26450155
http://dx.doi.org/10.1186/s12883-015-0448-4

Ejemplares similares